share_log
Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>

赛默飞世尔(TMO.US)证实其产品能检测出Omicron变体

Thermo Fisher Scientific Inc (TMO.US) confirmed that his product can detect Omicron variants.

智通財經 ·  11/29/2021 16:20

智通财经APP获悉,赛默飞世尔(TMO.US)已证实其用于检测新冠病毒的TaqPath COVID-19系列组合试剂盒和TaqPath COVID-19 CE-IVD RT-PCR试剂盒不受新出现的B.1.1.529即Omicron变异体的影响,能够实现精准的检测结果。

Omicron 变异体仅在刺突蛋白中就有30多个突变。世界卫生组织(WHO)和欧洲疾控中心都报告称,利用PCR检测的S基因靶向失效作为该变异的检测替代技术,有助于检测并识别Omicron。

据了解,这种新型变异病毒最初是在南非发现,现在世界上有10多个国家报告了感染该病毒的病例。

据悉,除了最初研发的TaqPath COVID-19检测试剂,赛默飞世尔还研发了TaqPath COVID-19 2.0检测试剂,采用了更先进的检测设计,以加强对新出现的突变体检测的精准度。

南非疫情应对与创新中心(CERI)负责人Tulio De Oliveira此前曾表示:“赛默飞世尔的检测试剂使我们能够通过鉴定表现出S基因缺失的样本,检测出可能含有新变异体的病例。”

Risk disclosure: The above content only represents the opinion of the authors or guests, and does not represent any positions of Futu or constitute any investment advice on the part of Futu. Before making any investment decision, investors should consider the risk factors related to investment products based on their own circumstances and consult professional investment advisers where necessary. Futu makes every effort to verify the authenticity, accuracy, and originality of the above content, but does not make any guarantees or promises.